LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Intra-articular injection of microRNA-140 (miRNA-140) alleviates osteoarthritis (OA) progression by modulating extracellular matrix (ECM) homeostasis in rats.

    Si, H-B / Zeng, Y / Liu, S-Y / Zhou, Z-K / Chen, Y-N / Cheng, J-Q / Lu, Y-R / Shen, B

    Osteoarthritis and cartilage

    2017  Volume 25, Issue 10, Page(s) 1698–1707

    Abstract: Objective: Disruptions of extracellular matrix (ECM) homeostasis are key events in the pathogenesis of osteoarthritis (OA). MicroRNA-140 (miRNA-140) is expressed specifically in cartilage and regulates ECM-degrading enzymes. Our objective in this study ... ...

    Abstract Objective: Disruptions of extracellular matrix (ECM) homeostasis are key events in the pathogenesis of osteoarthritis (OA). MicroRNA-140 (miRNA-140) is expressed specifically in cartilage and regulates ECM-degrading enzymes. Our objective in this study was to determine if intra-articular injection of miRNA-140 can attenuate OA progression in rats.
    Design: miRNA-140 levels in human normal and OA cartilage derived chondrocytes and synovial fluid were assessed by polymerase chain reaction (PCR). After primary human chondrocytes were transfected with miRNA-140 mimic or inhibitor, PCR and western blotting were performed to quantify Collagen II, MMP-13, and ADAMTS-5 expression. An OA model was induced surgically in rats, and subsequently treated with one single intra-articular injection of miRNA-140 agomir. At 4, 8, and 12 weeks after surgery, OA progression were evaluated macroscopically, histologically, and immunohistochemically in these rats.
    Results: miRNA-140 levels were significantly reduced in human OA cartilage derived chondrocytes and synovial fluid compared with normal chondrocytes and synovial fluid. Overexpressing miRNA-140 in primary human chondrocytes promoted Collagen II expression and inhibited MMP-13 and ADAMTS-5 expression. miRNA-140 levels in rat cartilage were significantly higher in the miRNA-140 agomir group than in the control group. Moreover, behavioural scores, chondrocyte numbers, cartilage thickness and Collagen II expression levels in cartilage were significantly higher, while pathological scores and MMP-13 and ADAMTS-5 expression levels were significantly lower in the miRNA-140 agomir group than in the control group.
    Conclusion: Intra-articular injection of miRNA-140 can alleviate OA progression by modulating ECM homeostasis in rats, and may have potential as a new therapy for OA.
    MeSH term(s) ADAMTS5 Protein/biosynthesis ; ADAMTS5 Protein/genetics ; Adult ; Aged ; Aged, 80 and over ; Animals ; Arthritis, Experimental/drug therapy ; Arthritis, Experimental/metabolism ; Arthritis, Experimental/pathology ; Cartilage, Articular/metabolism ; Cartilage, Articular/pathology ; Cells, Cultured ; Chondrocytes/metabolism ; Collagen Type II/biosynthesis ; Collagen Type II/genetics ; Disease Progression ; Drug Evaluation, Preclinical/methods ; Extracellular Matrix/drug effects ; Extracellular Matrix/physiology ; Gene Expression Regulation/physiology ; Homeostasis/drug effects ; Humans ; Injections, Intra-Articular ; Male ; Matrix Metalloproteinase 13/biosynthesis ; Matrix Metalloproteinase 13/genetics ; MicroRNAs/administration & dosage ; MicroRNAs/metabolism ; MicroRNAs/pharmacology ; MicroRNAs/therapeutic use ; Middle Aged ; Osteoarthritis/drug therapy ; Osteoarthritis/metabolism ; Osteoarthritis/pathology ; Rats, Sprague-Dawley ; Synovial Fluid/metabolism ; Young Adult
    Chemical Substances Collagen Type II ; MIRN140 microRNA, rat ; MicroRNAs ; Mirn140 microRNA, human ; ADAMTS5 Protein (EC 3.4.24.-) ; ADAMTS5 protein, human (EC 3.4.24.-) ; Matrix Metalloproteinase 13 (EC 3.4.24.-)
    Language English
    Publishing date 2017
    Publishing country England
    Document type Journal Article
    ZDB-ID 1167809-4
    ISSN 1522-9653 ; 1063-4584
    ISSN (online) 1522-9653
    ISSN 1063-4584
    DOI 10.1016/j.joca.2017.06.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Pharmacokinetics of doxycycline in laying hens after intravenous and oral administration.

    Yang, F / Si, H B / Wang, Y Q / Zhao, Z S / Zhou, B H / Hao, X Q

    British poultry science

    2016  Volume 57, Issue 4, Page(s) 576–580

    Abstract: The pharmacokinetics of doxycycline in laying hens was investigated after a single intravenous (IV) or an oral (PO) dose at 20 mg/kg body weight. The concentrations of doxycycline in plasma samples were determined by high-performance liquid ... ...

    Abstract The pharmacokinetics of doxycycline in laying hens was investigated after a single intravenous (IV) or an oral (PO) dose at 20 mg/kg body weight. The concentrations of doxycycline in plasma samples were determined by high-performance liquid chromatography with an ultraviolet detector, and pharmacokinetic parameters were calculated using a compartmental model method. The disposition of doxycycline after one single IV injection was best described by a two-compartment open model and the main pharmacokinetic parameters were as follows: volume of distribution (Vd) was 865.15 ± 127.64 ml/kg, distribution rate constant (α) was (2.28 ± 0.38) 1/h, elimination rate constant (β) was 0.08 ± 0.02 1/h and total body clearance (Cl) was104.11 ± 18.32 ml/h/kg, while after PO administration, the concentration versus time curve was best described by a one-compartment open model and absorption rate constant (Ka), peak concentration (Cmax), time to reach Cmax (tmax) and absolute bioavailability (F) were 2.55 ± 1.40 1/h, 5.88 ± 0.70 μg/ml, 1.73 ± 0.75 h and 52.33%, respectively. The profile of doxycycline exhibited favourable pharmacokinetic characteristics in laying hens, such as quick absorption and slow distribution and elimination, though oral bioavailability was relatively low. A multiple-dosing regimen (a dose of 20 mg/kg/d for 3 consecutive days) of doxycycline was recommended to treat infections in laying hens. But a further study should be conducted to determine the withdrawal time of doxycycline in eggs.
    MeSH term(s) Administration, Oral ; Animals ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/pharmacokinetics ; Biological Availability ; Chickens/metabolism ; Chromatography, High Pressure Liquid ; Dose-Response Relationship, Drug ; Doxycycline/administration & dosage ; Doxycycline/pharmacokinetics ; Female ; Injections, Intravenous/veterinary
    Chemical Substances Anti-Bacterial Agents ; Doxycycline (N12000U13O)
    Language English
    Publishing date 2016-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 956653-3
    ISSN 1466-1799 ; 0007-1668
    ISSN (online) 1466-1799
    ISSN 0007-1668
    DOI 10.1080/00071668.2016.1184228
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top